City

Basking Ridge (1)

Commack (1)

Harrison (1)

Middletown (1)

Montvale (1)

New York (1)

Tuebingen (1)

Uniondale (1)

Condition

Dysgerminoma (2)

Germ Cell Tumor (1)

Germinomatous Germ Cell Tumor (1)

Nonseminomatous Germ Cell Tumor (1)

Pineal Germ Cell Tumor (1)

Seminoma (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Sign in for free

Phase

phase 2 (2)

Sponsor

Memorial Sloan Kettering Cancer Center (1)

University Hospital Tuebingen (1)

Collaborator

AstraZeneca (1)

Intervention

darbepoetin alfa (1)

durvalumab (1)

tremelimumab (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (2)

Study Type

Interventional (2)

dysgerminoma

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Germ Cell Tumor, Nonseminomatous Germ Cell Tumor, Seminoma Trial in United States (Durvalumab, Tremelimumab)

Active, not recruiting

Germ Cell Tumor
+5 more

Basking Ridge, New Jersey
+6 more

May 2, 2022

Dysgerminoma Trial in Tuebingen (Darbepoetin alfa)

Completed

Dysgerminoma

Darbepoetin alfa

Tuebingen, Germany

Medical Center II, University of Tuebingen

Feb 13, 2009